{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:01Z","timestamp":1787027041819,"version":"build-2736575974"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Combination therapy of anticancer drugs with antibacterial agents has numerous advantages, but these may develop adverse drug events that were rarely studied. Specifically, regorafenib (REGO) mediates ferroptosis and causes liver injury when used in combination with aminoglycosides (AGs); however, this interaction remains unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>\n                      The study was conducted using both\n                      <jats:italic>in vivo<\/jats:italic>\n                      and\n                      <jats:italic>in vitro<\/jats:italic>\n                      assays involving Sprague\u2013Dawley (SD) rats and HepG2\/Huh7 to investigate ferroptosis-associated liver injury. The drugs REGO, amikacin (AMK), and gentamicin (GNT) were administered individually as well as in combination to evaluate their noxious effects on the liver. Subsequently, biochemical, histological, and transcriptomic analyses were carried out, and protein expressions were investigated using the immunoblotting assay to explore the mechanisms underlying ferroptotic-mediated liver injury.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The findings of the\n                      <jats:italic>in vivo<\/jats:italic>\n                      assay revealed that the combination therapy of regorafenib with aminoglycosides augments alanine transaminase (180%\u2013200%), aspartate aminotransferase (120%\u2013140%), malondialdehyde, and Fe\n                      <jats:sup>2+<\/jats:sup>\n                      levels. It decreases the level of antioxidants and alters histomorphology in SD rats compared to individual therapy. The\n                      <jats:italic>in vitro<\/jats:italic>\n                      assay results validate the enhanced levels of cellular iron, lipid peroxidation, reactive oxygen species, and lactate dehydrogenase release, indicating enhanced toxicity. In contrast, it decreased the cell viability ratio, glutathione level, and integrity of the mitochondrial membrane. The real-time quantitative polymerase chain reaction (RT-qPCR) and immunoblotting assay results show downregulation of GPX4 and SLC7A11 expressions, along with elevation of ALOX-15 (3- to 6-fold change).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Thus, combination therapy of regorafenib with amikacin and gentamycin causes significant elevation of iron and lipid peroxidation levels and alteration in protein expressions, which mediates ferroptotic cell death and leads to liver injury.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1586578","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T04:10:20Z","timestamp":1752552620000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Synergistic effect of regorafenib with aminoglycosides in ferroptosis-mediated liver injury"],"prefix":"10.3389","volume":"16","author":[{"given":"Maha","family":"Raja Dahar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lushan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1445-5994.2011.02452.x","article-title":"Current use of aminoglycosides: indications, pharmacokinetics, and monitoring for toxicity","volume":"41","author":"Avent","year":"2011","journal-title":"Intern. Med. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.20892\/j.issn.2095-3941.2020.0069","article-title":"Current management of chemotherapy-induced neutropenia in adults: key points and new challenges","volume":"17","author":"Ba","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"102427","DOI":"10.1016\/j.ctrv.2022.102427","article-title":"Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: a review","volume":"109","author":"Blayney","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/CIRCULATIONAHA.122.060257","article-title":"Alox15\/15-HpETE aggravates myocardial ischemia-reperfusion injury by promoting cardiomyocyte ferroptosis","volume":"147","author":"Cai","year":"2023","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.3390\/ijms21144908","article-title":"Ferroptosis in liver diseases: an overview","volume":"21","author":"Capelletti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrd2243","article-title":"Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases","volume":"6","author":"Casero","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"B7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13045-024-01564-3","article-title":"Ferroptosis: principles and significance in health and disease","volume":"17","author":"Chen","year":"2024","journal-title":"J. Hematol. and Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","article-title":"The multifaceted role of ferroptosis in liver disease","volume":"29","author":"Chen","year":"2022","journal-title":"Cell death Differ."},{"key":"B9","doi-asserted-by":"publisher","first-page":"637162","DOI":"10.3389\/fcell.2021.637162","article-title":"Characteristics and biomarkers of ferroptosis","volume":"9","author":"Chen","year":"2021","journal-title":"Front. cell Dev. Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"590226","DOI":"10.3389\/fcell.2020.590226","article-title":"Iron metabolism in ferroptosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front. cell Dev. Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41419-023-05716-0","article-title":"The interaction between ferroptosis and inflammatory signaling pathways","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death and Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e23507","DOI":"10.1016\/j.heliyon.2023.e23507","article-title":"The application of approaches in detecting ferroptosis","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"key":"B13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4103\/0971-5851.177015","article-title":"Chemotherapy-induced adverse drug reactions in oncology patients: a prospective observational survey","volume":"37","author":"Chopra","year":"2016","journal-title":"Indian J. Med. Pediatr. Oncol. official J. Indian Soc. Med. and Paediatr. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/metabo14040228","article-title":"Iron absorption: molecular and pathophysiological aspects","volume":"14","author":"Correnti","year":"2024","journal-title":"Metabolites"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1021\/cb4007024","article-title":"A novel use of gentamicin in the ROS-mediated sensitization of NCI-H460 lung cancer cells to various anticancer agents","volume":"8","author":"Cuccarese","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S1470-2045(23)00358-3","article-title":"First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial","volume":"24","author":"Cytryn","year":"2023","journal-title":"Lancet. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-1-0716-3433-2_6","article-title":"Probing lipid peroxidation in ferroptosis: emphasizing the utilization of C11-BODIPY-Based protocols","volume":"2712","author":"Dai","year":"2023","journal-title":"Methods Mol. Biol. Clift. N.J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/CMAR.S386181","article-title":"Chemotherapy induced neutropenia, febrile-neutropenia and determinants among solid cancer patients attending oncology unit of a tertiary care teaching hospital in Ethiopia","volume":"15","author":"Dessalegn","year":"2023","journal-title":"Cancer Manag. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-60761-411-1_4","article-title":"Identification of ROS using oxidized DCFDA and flow-cytometry","volume":"594","author":"Eruslanov","year":"2010","journal-title":"Methods Mol. Biol. Clift. N.J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"8629024","DOI":"10.1155\/2016\/8629024","article-title":"Dual role of ROS as signal and stress agents: iron tips the balance in favor of toxic effects","volume":"112","author":"Gammella","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2147\/JHC.S251729","article-title":"Regorafenib combined with other systemic therapies: exploring promising therapeutic combinations in HCC","volume":"8","author":"Granito","year":"2021","journal-title":"J. Hepatocell. carcinoma"},{"key":"B23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/biom12030390","article-title":"Ferroptosis in cardiovascular diseases: current status, challenges, and future perspectives","volume":"12","author":"Guo","year":"2022","journal-title":"Biomolecules"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e2319429121","DOI":"10.1073\/pnas.2319429121","article-title":"Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer","volume":"121","author":"Han","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"119911","DOI":"10.1016\/j.biomaterials.2020.119911","article-title":"Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator","volume":"241","author":"He","year":"2020","journal-title":"Biomaterials"},{"key":"B26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","article-title":"The development of the concept of ferroptosis","volume":"133","author":"Hirschhorn","year":"2019","journal-title":"Free Radic. Biol. and Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00467-017-3715-3","article-title":"Liver involvement in kidney disease and vice versa","volume":"33","author":"Hoeve","year":"2018","journal-title":"Pediatr. Nephrol. Berl. Ger."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1080\/21655979.2022.2045834","article-title":"Platycodin D regulates high glucose-induced ferroptosis of HK-2 cells through glutathione peroxidase 4 (GPX4)","volume":"13","author":"Huang","year":"2022","journal-title":"Bioengineered"},{"key":"B29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4103\/iju.IJU_494_20","article-title":"Efficacy of 1 versus 3 days of intravenous amikacin as a prophylaxis for patients undergoing transurethral resection of the prostate: a prospective randomized trial","volume":"37","author":"Jayanth","year":"2021","journal-title":"Indian J. Urology IJU J. Urological Soc. India"},{"key":"B30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology, and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. cell Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41591-024-02824-y","article-title":"Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial","volume":"30","author":"Kim","year":"2024","journal-title":"Nat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"8778","DOI":"10.1074\/jbc.M114.625053","article-title":"Cystathionine is a novel substrate of cystine\/glutamate transporter: implications for immune function","volume":"290","author":"Kobayashi","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bbalip.2014.10.002","article-title":"Mammalian lipoxygenases and their biological relevance","volume":"1851","author":"Kuhn","year":"2015","journal-title":"Biochimica biophysica acta"},{"key":"B35","doi-asserted-by":"publisher","first-page":"95497","DOI":"10.1101\/pdb.prot095497","article-title":"Analysis of cell viability by the lactate dehydrogenase assay","volume":"2018","author":"Kumar","year":"2018","journal-title":"Cold Spring Harb. Protoc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/wjo2.213","article-title":"Expression and clinical significance of the p53\/SAT1\/ALOX15 ferroptosis-associated proteins in sinonasal inverted papilloma","volume":"222","author":"Li","year":"2024","journal-title":"World J. Otorhinolaryngology - Head Neck Surg."},{"key":"B37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death and Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"992611","DOI":"10.3389\/fimmu.2022.992611","article-title":"Immunomodulatory effects of regorafenib: enhancing the efficacy of anti-PD-1\/PD-L1 therapy","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2282566","DOI":"10.1080\/21623945.2023.2282566","article-title":"Ojeok-san enhances platinum sensitivity in ovarian cancer by regulating adipocyte paracrine IGF1 secretion","volume":"13","author":"Ma","year":"2024","journal-title":"Adipocyte"},{"key":"B40","doi-asserted-by":"publisher","first-page":"22244","DOI":"10.1074\/jbc.M110.121327","article-title":"System x(c)- and thioredoxin reductase 1 cooperatively rescue glutathione deficiency","volume":"285","author":"Mandal","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3748\/wjg.v25.i5.521","article-title":"Iron and liver fibrosis: mechanistic and clinical aspects","volume":"25","author":"Mehta","year":"2019","journal-title":"World J. Gastroenterology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/FTD.0b013e3181570791","article-title":"An improved application for the enzyme multipled immunoassay technique for caffeine, amikacin, and methotrexate assays on the Dade-Behring dimension RxL max clinical chemistry system","volume":"29","author":"Mendu","year":"2007","journal-title":"Ther. Drug Monit."},{"key":"B43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3816\/SCT.2006.n.018","article-title":"Role of prophylactic antibiotics in the prevention of infections after chemotherapy: a literature review","volume":"3","author":"Moon","year":"2006","journal-title":"Support. cancer Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e001657","DOI":"10.1136\/jitc-2020-001657","article-title":"Regorafenib enhances antitumor immunity via inhibition of p38 kinase\/Creb1\/Klf4 axis in tumor-associated macrophages","volume":"9","author":"Ou","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"101502","DOI":"10.1016\/j.molmet.2022.101502","article-title":"Role and mechanism of ferroptosis in neurological diseases","volume":"61","author":"Ou","year":"2022","journal-title":"Mol. Metab."},{"key":"B46","doi-asserted-by":"publisher","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","article-title":"Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses","volume":"113","author":"Ou","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B47","doi-asserted-by":"publisher","first-page":"109739","DOI":"10.1016\/j.neuropharm.2023.109739","article-title":"CCK-8 enhances acid-sensing ion channel currents in rat primary sensory neurons","volume":"241","author":"Qin","year":"2023","journal-title":"Neuropharmacology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.22074\/cellj.2023.2007757.1376","article-title":"Review on kidney-liver crosstalk: pathophysiology of their disorders","volume":"26","author":"Rad","year":"2024","journal-title":"Cell J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fncel.2020.00218","article-title":"Ferroptosis in neurological diseases","volume":"14","author":"Ren","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"176820","DOI":"10.1016\/j.ejphar.2024.176820","article-title":"Cerebroprotein hydrolysate-I ameliorates cognitive dysfunction in APP\/PS1 mice by inhibiting ferroptosis via the p53\/SAT1\/ALOX15 signalling pathway","volume":"979","author":"Ren","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/ijms24010449","article-title":"Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis","volume":"24","author":"Rochette","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.molcel.2021.12.001","article-title":"Persister cancer cells: iron addiction and vulnerability to ferroptosis","volume":"82","author":"Rodriguez","year":"2022","journal-title":"Mol. cell"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.3390\/cimb43030154","article-title":"Effect of regorafenib on P2X7 receptor expression and different oncogenic signaling pathways in a human breast cancer cell line: a potential of new insight of the antitumor effects of regorafenib","volume":"43","author":"Salahuddin","year":"2021","journal-title":"Curr. issues Mol. Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/ar.22578","article-title":"Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention","volume":"295","author":"Schacht","year":"2012","journal-title":"Anat. Rec. Hob. N. J. 2007"},{"key":"B55","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cld.2007.06.002","article-title":"Drug hepatotoxicity from a regulatory perspective","volume":"11","author":"Senior","year":"2007","journal-title":"Clin. Liver Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12967-022-03657-4","article-title":"Identification of SSBP1 as a ferroptosis-related biomarker of glioblastoma based on a novel mitochondria-related gene risk model and in vitro experiments","volume":"20","author":"Su","year":"2022","journal-title":"J. Transl. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/00007890-199306000-00011","article-title":"Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine","volume":"55","author":"Suzuki","year":"1993","journal-title":"Transplantation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.fct.2018.11.041","article-title":"Adverse drug reactions of anticancer drugs derived from natural sources","volume":"123","author":"Tewari","year":"2019","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Industrial Biol. Res. Assoc."},{"key":"B61","doi-asserted-by":"publisher","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr. Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ab.2016.10.021","article-title":"Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges","volume":"524","author":"Tsikas","year":"2017","journal-title":"Anal. Biochem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/j.akdh.2024.02.003","article-title":"The kidney and liver disease connection","volume":"31","author":"Velez","year":"2024","journal-title":"Adv. Kidney Dis. Health"},{"key":"B64","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/s0300-483x(02)00612-1","article-title":"Immunosuppressive drugs and cancer","volume":"185","author":"Vial","year":"2003","journal-title":"Toxicology"},{"key":"B65","first-page":"E2","article-title":"Drug-associated blood cell dyscrasias","volume":"34","author":"Weiss","year":"2012","journal-title":"Compend. (Yardley, PA)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ijc.25864","article-title":"Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity","volume":"129","author":"Wilhelm","year":"2011","journal-title":"Int. J. Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41420-021-00660-4","article-title":"Ferroptosis in liver disease: new insights into disease mechanisms","volume":"7","author":"Wu","year":"2021","journal-title":"Cell death Discov."},{"key":"B68","doi-asserted-by":"publisher","first-page":"127807","DOI":"10.1016\/j.jhazmat.2021.127807","article-title":"Di-(2-ethylhexyl) phthalate exposure leads to ferroptosis via the HIF-1\u03b1\/HO-1 signaling pathway in mouse testes","volume":"426","author":"Wu","year":"2022","journal-title":"J. Hazard. Mater."},{"key":"B69","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3892\/ol.2022.13186","article-title":"MicroRNA-15a promotes prostate cancer cell ferroptosis by inhibiting GPX4 expression","volume":"23","author":"Xu","year":"2022","journal-title":"Oncol. Lett."},{"key":"B70","doi-asserted-by":"publisher","first-page":"11317","DOI":"10.3390\/ijms252011317","article-title":"SAT1\/ALOX15 signaling pathway is involved in ferroptosis after skeletal muscle contusion","volume":"25","author":"Yang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"B72","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1080\/15384101.2023.2278328","article-title":"Role and mechanism of ferroptosis in acute lung injury","volume":"22","author":"Yu","year":"2023","journal-title":"Cell cycleGeorget. Tex."},{"key":"B74","doi-asserted-by":"publisher","first-page":"115852","DOI":"10.1016\/j.jep.2022.115852","article-title":"Qing-xin-jie-yu granule inhibits ferroptosis and stabilizes atherosclerotic plaques by regulating the GPX4\/xCT signaling pathway","volume":"301","author":"Zhang","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"93813","DOI":"10.18632\/oncotarget.21217","article-title":"Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"B76","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","article-title":"The metabolic underpinnings of ferroptosis","volume":"32","author":"Zheng","year":"2020","journal-title":"Cell metab."},{"key":"B77","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1002\/jcp.30901","article-title":"The role of ferroptosis in the development of acute and chronic kidney diseases","volume":"237","author":"Zhou","year":"2022","journal-title":"J. Cell. physiology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1473-3099(10)70089-X","article-title":"Mandell, douglas, and Bennett\u2019s principles and practice of infectious diseases","volume":"10","author":"Zumla","year":"2010","journal-title":"Lancet Infect. Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1586578\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T04:10:21Z","timestamp":1752552621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1586578\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":78,"alternative-id":["10.3389\/fphar.2025.1586578"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1586578","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"article-number":"1586578"}}